IR-News

AUSSENDER



Marinomed Biotech AG
Ansprechpartner: Dr. Eva Prieschl-Grassauer
Tel.: +43 2262 90300
E-Mail: eva.prieschl@marinomed.com
pta20201022033
Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Marinomed Biotech AG: Release according to art. 135 section 2 BörseG


Vienna (pta033/22.10.2020/16:00) - Release of Announcement according to art. 135 section 2 BörseG

Notification of Major Holdings

1. Issuer:
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: Erste Asset Management GmbH
City and country of registered office: Vienna, Austria

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3


5. Date on which threshold was crossed or reached
20.10.2020

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached 10.32 0.00 10.32 1,472,034
Position of previous notification 7.71 7.71

7. Notified details of the resulting situation

7.a. Voting rights attached to shares

ISIN code absolute direct (Sec 130 BörseG 2018) absolute indirect (Sec 133 BörseG 2018) in % direct (Sec 130 BörseG 2018) in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 151,850 0 10.32 0.00
Total: 151,850 10.32

7.b.1. Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument Expiration Date Exercise Period Voting Rights Absolute Voting Rights in %
Total:

7.b.2 Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

Type of instrument Expiration Date Exercise Period Physical /Cash Settlement Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

No. Name Directly controlled by No. Shares held directly (%) Financial/other instruments held directly (%) Total of both (%)

9. In case of proxy voting

Date of general meeting: N/A

10. Additional Information
The voting rights held by Erste Asset Management GmbH as stated in section 8 are not held directly but by the investment funds managed by the management company. They are therefore not holdings of the management company.

(end)
emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
contact person: Dr. Eva Prieschl-Grassauer
phone: +43 2262 90300
e-mail: eva.prieschl@marinomed.com
website: www.marinomed.com
stock exchanges: official trade in Vienna
ISIN(s): ATMARINOMED6 (share)
|
|
97.996 Abonnenten
|
185.388 Meldungen
|
75.921 Pressefotos

BUSINESS

03.12.2020 - 13:55 | pressetext.redaktion
03.12.2020 - 10:45 | IG Windkraft
03.12.2020 - 10:15 | danberg&danberg.
03.12.2020 - 06:10 | pressetext.redaktion
02.12.2020 - 17:40 | PRofessional PR
Top